[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"doc-seo-334013-105":3,"detail-sidebar-cat-0-en-105":81,"doc-detail-334013-en":130},{"code":4,"msg":5,"data":6},0,"ok",{"site_id":7,"language":8,"slug":9,"title":10,"keywords":11,"description":12,"schema_data":13,"social_meta":74,"head_meta":76,"extra_data":78,"updated_unix":80},105,"en","clinicopathological-risk-factors-of-oral-second-primary-tumours","Clinicopathological risk factors of oral second primary tumours","","Oral second primary tumours (SPTs) lead to poor outcomes largely because diagnosis often occurs at a late stage. This study evaluates demographic and clinicopathological risk predictors for SPTs using patients enrolled in the Oral Cancer Prediction Longitudinal study after curative treatment. Older age at primary cancer diagnosis and habits such as chewing tobacco or betel nut increased risk. Low-risk primary sites, second oral premalignant lesions (SOPLs), and multiple lesions further raised SPT risk. The median time to diagnosis was 3.25 years after treatment.",{"@graph":14,"@context":73},[15,34,56],{"@type":16,"itemListElement":17},"BreadcrumbList",[18,23,27,31],{"item":19,"name":20,"@type":21,"position":22},"https://docshare.wps.com","Home","ListItem",1,{"item":24,"name":25,"@type":21,"position":26},"https://docshare.wps.com/document/","Document",2,{"item":28,"name":29,"@type":21,"position":30},"https://docshare.wps.com/document/research-report/","Research & Report",3,{"item":32,"name":10,"@type":21,"position":33},"https://docshare.wps.com/document/clinicopathological-risk-factors-of-oral-second-primary-tumours/334013/",4,{"url":32,"name":10,"@type":35,"image":36,"author":41,"headline":10,"publisher":44,"fileFormat":47,"inLanguage":8,"description":12,"dateModified":48,"datePublished":49,"encodingFormat":47,"isAccessibleForFree":50,"interactionStatistic":51},"DigitalDocument",{"url":37,"@type":38,"width":39,"height":40},"https://docshare.wps.com/thumbnails/clinicopathological-risk-factors-of-oral-second-primary-tumours/334013.png","ImageObject",300,407,{"name":42,"@type":43},"Sage","Person",{"url":19,"name":45,"@type":46},"DocShare","Organization","application/pdf","2026-11-03","2026-09-21",true,{"@type":52,"interactionType":53,"userInteractionCount":55},"InteractionCounter",{"@type":54},"ViewAction",10,{"@type":57,"mainEntity":58},"FAQPage",[59,65,69],{"name":60,"@type":61,"acceptedAnswer":62},"What patient factors increased the risk of oral second primary tumours (SPTs)?","Question",{"text":63,"@type":64},"Older age at primary cancer diagnosis and a history of chewing tobacco or betel nut increased SPT risk.","Answer",{"name":66,"@type":61,"acceptedAnswer":67},"How do second oral premalignant lesions (SOPLs) relate to SPT development?",{"text":68,"@type":64},"The presence of SOPLs significantly increased the risk of SPTs, and multiple lesions also raised risk.",{"name":70,"@type":61,"acceptedAnswer":71},"What is the role of toluidine blue staining and fluorescence visualization in assessing SPT risk?",{"text":72,"@type":64},"Positive toluidine blue staining indicated a trend toward higher SPT risk, while fluorescence visualization did not show the same trend.","https://schema.org",{"og:url":32,"og:type":75,"og:title":10,"og:site_name":45,"og:description":12},"article",{"robots":77,"canonical":32},"index,follow",{"doc_id":79,"site_id":7},334013,1790331823,{"code":4,"msg":82,"data":83},"success",[84,88,92,96,101,106,111,115,120,123,126],{"id":22,"doc_module":4,"doc_module_name":25,"category_name":85,"show_sort_weight":86,"slug":87},"Story & Novel",90,"story-novel",{"id":26,"doc_module":4,"doc_module_name":25,"category_name":89,"show_sort_weight":90,"slug":91},"Literature",80,"literature",{"id":33,"doc_module":4,"doc_module_name":25,"category_name":93,"show_sort_weight":94,"slug":95},"Exam",70,"exam",{"id":97,"doc_module":4,"doc_module_name":25,"category_name":98,"show_sort_weight":99,"slug":100},5,"Comic",60,"comic",{"id":102,"doc_module":4,"doc_module_name":25,"category_name":103,"show_sort_weight":104,"slug":105},6,"Technology",50,"technology",{"id":107,"doc_module":4,"doc_module_name":25,"category_name":108,"show_sort_weight":109,"slug":110},7,"Healthcare",40,"healthcare",{"id":112,"doc_module":4,"doc_module_name":25,"category_name":29,"show_sort_weight":113,"slug":114},8,30,"research-report",{"id":116,"doc_module":4,"doc_module_name":25,"category_name":117,"show_sort_weight":118,"slug":119},9,"Religion & Spirituality",20,"religion-spirituality",{"id":118,"doc_module":4,"doc_module_name":25,"category_name":121,"show_sort_weight":118,"slug":122},"World Cup","world-cup",{"id":55,"doc_module":4,"doc_module_name":25,"category_name":124,"show_sort_weight":55,"slug":125},"Lifestyle","lifestyle",{"id":127,"doc_module":4,"doc_module_name":25,"category_name":128,"show_sort_weight":97,"slug":129},19,"General","general",{"code":4,"msg":82,"data":131},{"doc_id":79,"user_id":132,"nickname":42,"user_avatar":133,"doc_module":4,"category_id":112,"category_name":29,"doc_title":10,"doc_description":12,"doc_content":134,"file_id":135,"file_url":136,"file_type":137,"file_size":138,"view_count":55,"is_deleted":4,"is_public":22,"is_downloadable":22,"audit_status":22,"page_count":139,"language":140,"language_code":8,"site_id":7,"html_lang":8,"table_of_contents":141,"faqs":142,"seo_title":143,"seo_description":12,"update_tm":144,"read_time":145,"preview_page_count":4},687197207057,"https://ap-avatar.wpscdn.com/davatar_29158cc5080c5b710cf443261637dec0","Author Manuscript Author Manuscript Author Manuscript Author Manuscript  \n\n| | HHS Public Access\u003Cbr>Author manuscript\u003Cbr>Oral Oncol Rep. Author manuscript; available in PMC 2024 October 31. |\n| --- | --- |\n\nPublished in final edited form as:  \nOral Oncol Rep. 2024 September ; 11: . doi:10.1016/j.oor.2024.100638 .  \nClinicopathological risk factors of oral second primary tumours  \nJelena Karana,* , Miriam P. Rosinb,c, Lewei Zhanga, Denise M. Larondea,b  \na Faculty of Dentistry, University of British Columbia, 2199 Wesbrook Mall, Vancouver, BC, Canada, V6T1Z3  \nbCancer Control Research, British Columbia Cancer Agency, 675 W10th Avenue, Vancouver, BC, Canada, V5Z 1L3  \nc Department of Biomedical Physiology and Kinesiology, Simon Fraser University, 8888 University Dr, Burnaby, BC, Canada, V5A 1S6  \nAbstract  \nBackground: Oral second primary tumours (SPTs) have a poor prognosis due to late-stage diagnosis. This study evaluates the demographic and clinicopathological risk predictors of SPTs.  \nMethods: Patients with oral squamous cell carcinoma, carcinoma in situ, or severe dysplasia were accrued into the Oral Cancer Prediction Longitudinal study within one year post-curative treatment. Data on demographics, risk habits, and primary tumour characteristics were collected.  \nClinical follow-up included assessing the presence of second oral premalignant lesions (SOPLs), clinicopathological features, and the results from toluidine blue staining and fluorescence  \nvisualization.  \nResults: Among 296 patients, 23 (8 %) developed SPTs. Older age at primary cancer diagnosis (P = 0.008) and a history of chewing tobacco or betel nut (P = 0.043) increased the risk of SPTs.  \nPatients with primary tumours located at low-risk sites had an increased risk of SPTs (P = 0.004), which often presented at high-risk sites. The presence of SOPLs (P \u003C 0.001), and multiple lesions (P = 0.017) significantly increased the risk of SPTs. Positive toluidine blue staining indicated a trend toward higher risk of SPTs, whereas fluorescence visualization did not. The median time to SPT diagnosis was 3.25 years post-treatment.  \nConclusions: Identifying second or multiple oral premalignant lesions is critical for predicting the risk of SPTs regardless of their clinical or histological characteristics. Routine biopsy of these  \nThis is an open access article under the CC BY-NC-ND license ([http://creativecommons.org/licenses/by-nc-nd/4.0/](http://creativecommons.org/licenses/by-nc-nd/4.0/)).  \n*[Corresponding author. jelena.karan@dentistry.ubc.ca](Corresponding author. jelena.karan@dentistry.ubc.ca) (J. Karan) .  \nCRediT authorship contribution statement  \nJelena Karan: Conceptualization, Data curation, Formal analysis, Investigation, Methodology, Project administration, Validation, Visualization, Writing – original draft. Miriam P. Rosin: Conceptualization, Funding acquisition, Project administration, Resources, Supervision, Writing – review & editing. Lewei Zhang: Data curation, Funding acquisition, Resources. Denise M. Laronde: Conceptualization, Data curation, Funding acquisition, Methodology, Project administration, Supervision, Validation, Writing – review & editing.  \nDeclaration of competing interest  \nThe authors declare that they have no known competing financial interests or personal relationships that could have appeared to influence the work reported in this paper.  \nAppendix A. Supplementary data  \nSupplementary data to this article can be found online at [https://doi.org/10.1016/j.oor.2024.100638](https://doi.org/10.1016/j.oor.2024.100638) .  \nAuthor Manuscript Author Manuscript Author Manuscript Author Manuscript  \nKaran et al. Page 2  \nlesions should be prioritized to ensure timely diagnosis. Incorporating these risk predictors into clinical follow-up can enhance early cancer detection and improve patient outcomes.  \nKeywords  \nOral cancer; Head and neck cancer; Squamous cell carcinoma; Second primary cancer; Risk factors; Tobacco use; Betel nut; Tol","cbCaig6SSef5OXIn","https://ap.wps.com/l/cbCaig6SSef5OXIn","pdf",578467,17,"English","# Abstract\n# Background\n# Methods\n# Results\n# Conclusions\n# Keywords\n# 1. Introduction","[{\"question\":\"What patient factors increased the risk of oral second primary tumours (SPTs)?\",\"answer\":\"Older age at primary cancer diagnosis and a history of chewing tobacco or betel nut increased SPT risk.\"},{\"question\":\"How do second oral premalignant lesions (SOPLs) relate to SPT development?\",\"answer\":\"The presence of SOPLs significantly increased the risk of SPTs, and multiple lesions also raised risk.\"},{\"question\":\"What is the role of toluidine blue staining and fluorescence visualization in assessing SPT risk?\",\"answer\":\"Positive toluidine blue staining indicated a trend toward higher SPT risk, while fluorescence visualization did not show the same trend.\"}]","Clinicopathological risk factors of oral second primary tumours | PDF",1790004991,43]